Reported Earlier, Spyre Therapeutics Prices $350M Public Offering Of 4,117,648 Common Shares At $85.00 Per Share, Plans To Fund Gastroenterology, Rheumatology And Dermatology Programs

뉴스 본문을 불러오고 있어요.

Reported Earlier, Spyre Therapeutics Prices $350M Public Offering Of 4,117,648 Common Shares At $85.00 Per Share, Plans To Fund Gastroenterology, Rheumatology And Dermatology Programs | 웨이프 WAPE

Reported Earlier, Spyre Therapeutics Prices $350M Public Offering Of 4,117,648 Common Shares At $85.00 Per Share, Plans To Fund Gastroenterology, Rheumatology And Dermatology Programs

기사 요약

관련 종목

댓글 —